Giving to a Team CRI fundraiser provides critical funds to support our high-impact research programs. Every contribution brings us closer to establishing immunotherapy as a cure for all cancers.
Your support of CRI directly impacts the discovery and development of powerful immunotherapies for all types of cancers—funding more breakthroughs and saving more lives.
Immunotherapy has the profound potential to cure all types of cancer.
CRI funds the full spectrum of discovery, from lab to clinic to cure.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, 4th Floor | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
We introduce you to Rafael Amado, M.D., chief medical officer at Adaptimmune, a leader in T cell receptor (TCR) cancer immunotherapy.
On June 30, 2018, over 200 patients, caregivers, and advocates gathered to connect with experts and learn about the science of cancer immunotherapy in San Francisco.